Similar articles

• Impact of Clostridium difficile on inflammatory bowel disease.

  Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG. Issa M, et al. Clin Gastroenterol Hepatol. 2007 Mar;5(3):345-51. doi: 10.1016/j.cgh.2006.12.028. Clin Gastroenterol Hepatol. 2007. PMID: 17368234
• The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.

  Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C, Ross RP. Clayton EM, et al. Am J Gastroenterol. 2009 May;104(5):1162-9. doi: 10.1038/ajg.2009.4. Epub 2009 Mar 24. Am J Gastroenterol. 2009. PMID: 19319128
• Incidence of Clostridium difficile infection in inflammatory bowel disease.

  Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Rodemann JF, et al. Clin Gastroenterol Hepatol. 2007 Mar;5(3):339-44. doi: 10.1016/j.cgh.2006.12.027. Clin Gastroenterol Hepatol. 2007. PMID: 17368233
• The evolving epidemiology of inflammatory bowel disease.

  Shanahan F, Bernstein CN. Shanahan F, et al. Curr Opin Gastroenterol. 2009 Jul;25(4):301-5. doi: 10.1097/MOG.0b013e32832b12ef. Curr Opin Gastroenterol. 2009. PMID: 19349861 Review.
• Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.

  Prantera C, Scribano ML. Prantera C, et al. Curr Opin Gastroenterol. 2009 Jul;25(4):329-33. doi: 10.1097/MOG.0b013e32832b20bf. Curr Opin Gastroenterol. 2009. PMID: 19444096 Review.